4 products found
F. Hoffmann-La Roche Ltd. Products
-
Pharmaceuticals
-
Actemra/RoActemra (Tocilizumab)
Actemra/RoActemra is approved in 116 countries for the treatment of rheumatoid arthritis (RA). It is also approved for the treatment of paediatric juvenile idiopathic arthritis (pJIA), systemic juvenile idiopathic arthritis (sJIA), giant cell arteritis (GCA) and CAR-T cell-induced cytokine release syndrome (CRS). Actemra/RoActemra is available in both subcutaneous (SC) and intravenous (IV) ...
-
Alecensa (Alectinib)
Alecensa is a highly selective, central nervous system-active, oral medicine used for the treatment of people with non-small cell lung cancer (NSCLC) whose tumours are identified as anaplastic lymphoma kinase (ALK)-positive. Alecensa is a tyrosine kinase inhibitor that targets ALK fusion proteins, preventing signalling within cancer cells to inhibit their growth and ...
-
Avastin (Bevacizumab)
Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A). With the initial approval in the United States for advanced colorectal cancer in 2004, Avastin became the first anti-angiogenic therapy made widely available for the treatment of patients with an advanced ...
-
Copegus (ribavarin)
Copegus is an antiviral medication that, in combination with other medicinal products, is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C virus infection who have compensated liver disease and have not been previously treated with interferon ...